The efficacy of oral lumenoscopy™ (ViziLite®) in visualizing oral mucosal lesions

Special Care in Dentistry

Volumn 26, Issue 4, 2006, Pages 171-174

  Epstein, Joel B ^a,b   Gorsky, Meir ^a,c   Lonky, Stewart ^d   Silverman Jr , Sol ^e   Epstein, Joshua D ^f   Bride, Mark ^g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Zila Pharmaceuticals Incorporated   (United States)

Author keywords

Early detection; Leukoplakia; Oral premalignant lesions; Squamous cell carcinoma

Indexed keywords

ACETIC ACID; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; LEUKOPLAKIA; LICHEN PLANUS; LUMINESCENCE; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; MULTICENTER STUDY; PATHOLOGY; PRECANCER; RISK FACTOR; SMOKELESS TOBACCO; SMOKING;

ACETIC ACID; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDICATORS AND REAGENTS; LEUKOPLAKIA, ORAL; LICHEN PLANUS, ORAL; LUMINESCENCE; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

EID: 33749179050     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2006.tb01720.x     Document Type: Article

References (26)

1. Jemal A, Murray T, Ward E et al. Cancer Statistics, 2005. CA Cancer J Clin 2005;55:10-30,
2. Shiboski CH, Shiboski SC, Silverman S Jr. Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 2000;28:249-56.
3. Bouquot JE, Meckstroth RL. Oral cancer in a tobacco-chewing US population - no apparent increased incidence or mortality. Oral Surg Oral Med Oral Path Oral Radiol Endod 1998;86:697-706.
4. Martin-Granizo R, Rodriguez-Campo F, Naval L, Diaz Gonzalez FJ. Squamous cell carcinoma of the oral cavity in patients younger than 40 years. Otolaryngol Head Neck Surg 1997;117(3 Pt 1):268-75.
5. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001;132 Suppl:7S-11S.
6. National Cancer Institute. Surveillance, Epidemiology, and End Results Program public-use data, 1973-1998. Rockville, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Released April 2001, based on the August 2000 submission.
7. Silverman S Jr., Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53(3):563-8.
8. Anonymous. Perform a death-defying act. The 90-second oral cancer examination. J Am Dent Assoc 2001;132 Suppl:36S-40S.
9. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc 1999;130:1445-57.
10. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart PA. The sensitivity and specifity of the OralCDx technique: evaluation of 103 cases. Oral Oncol 2004;40:824-8.
11. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Path Oral Radiol Endod 1997;83:537-47.
12. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Path Oral Radiol Endod 2003;95:45-50.
13. Rosenberg D, Cretin S. Use of meta-analysis to evaluate toluidine blue in oral cancer screening. Oral Surg Oral Med Oral Path Oral Radiol Endod 1989;67:621-7.
14. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992;21:160-3.
15. Epstein JB, Feldman R, Dolor RJ, Porter SR. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 2003;25:911-21.
16. Chang JI, Ou CH, Wu KM, Chen CC, Cheng KC. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Chung Hua i Hsueh Tsa Chih - Chinese Medical Journal 2002;65:430-4.
17. Ciatto S. The Italian experience of a Pap test and speculoscopy based screening programme. J Med Screen 2001;8(1):54.
18. Loiudice L, Abbiati R, Boselli F, Cecchini G, Costa S, Grossi E, Piccoli R, Villani C. Improvement of Pap smear sensitivity using a visual adjunctive procedure: a co-operative Italian study on speculoscopy (GISPE). Eur J Cancer Prev 1998;7:295-304.
19. Silverman S Jr. Oral Cancer. 5th ed. Ontario: BC Decker Hamilton. 2003, p 33.
20. Casiglia J, Woo SB. A comprehensive review of oral cancer. Gen Dent 2001;49:72-82.
21. Kerr AR. Life saving oral cancer screening. NY State Dent J 2000;66:26-30.
22. Horowitz AM, Alfano MC. Performing a death-defying act. J Am Dent Assoc 2001 Nov;132 Suppl:5S-6S.
23. Kujan O, Glenny AM, Duxbury AJ, Thakker N, Sloan P. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2003;(4):CD004150.
24. Patton LL. The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol 2003;39:708-23.
25. Nagao T, Warnakulasuriya S. Annual screening for oral cancer detection. Cancer Detect Prev 2003;27:333-7.
26. Suneja A, Mahishee, Agarwal N, Misra K. Comparison of magnified chemiluminescent examination with incandescent light examination and colposcopy for detection of cervical neoplasia. Indian J Cancer 1998;35(2):81-7.